Joel Andrews

Emory University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

19h-index1.1kcitations119works7.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Phosphodiesterase function and regulation(41), DNA Repair Mechanisms(23), PARP inhibition in cancer therapy(20), Cancer, Hypoxia, and Metabolism(14), Mitochondrial Function and Pathology(11)

Publications119 total

Nerve-to-cancer transfer of mitochondria during cancer metastasis
Nature·2025· 55 citedOpen Access
TRIP12’s role in the governance of DNA polymerase β involvement in DNA damage response and repair
Nucleic Acids Research·2025· 4 citedOpen Access
The unseen burden of CTCL caregiving.
Journal of Clinical Oncology·2025
Development and characterization of a novel NEIL1 nanobody
DNA repair·2025· 1 cited
Overexpression of the WWE domain of RNF146 modulates poly-(ADP)-ribose dynamics at sites of DNA damage
DNA repair·2025· 4 citedOpen Access
In Vitro Phase Separation of PPM1B During Hypercapnia
American Journal of Respiratory and Critical Care Medicine·2025
Host–Parasite Interactions in Toxoplasma gondii-Infected Cells: Roles of Mitochondria, Microtubules, and the Parasitophorous Vacuole
International Journal of Molecular Sciences·2024· 6 citedOpen Access
Oncometabolite 2-hydroxyglutarate suppresses basal protein levels of DNA polymerase beta that enhances alkylating agent and PARG inhibition induced cytotoxicity
DNA repair·2024· 6 citedOpen Access
Microtubule Reorganization Promotes Endothelial Barrier Disruption During Pneumonia Infection
2024
TRIP12 governs DNA Polymerase β involvement in DNA damage response and repair
2024· 1 citedOpen Access
Overexpression of the WWE domain of RNF146 modulates poly-(ADP)-ribose dynamics at sites of DNA damage
2023· 1 citedOpen Access
Algorithm for biological second messenger analysis with dynamic regions of interest
PLoS ONE·2023· 4 citedOpen Access
Supplemental Figure 4B from Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin
2023Open Access
Supplemental Figure 4A from Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin
2023Open Access
Supplementary Methods, Figure Legend from Suppression of Ser/Thr Phosphatase 4 (PP4C/<i>PPP4C</i>) Mimics a Novel Post-Mitotic Action of Fostriecin, Producing Mitotic Slippage Followed by Tetraploid Cell Death
2023Open Access
Supplemental Figure 7 from Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin
2023Open Access
Supplemental Figure 1 from Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin
2023Open Access
Data from Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin
2023Open Access
Supplemental Figure 2A from Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin
2023Open Access
Supplemental Figure 4C from Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Robert W. Sobol(16), Jennifer Clark(10), Christopher A. Koczor(10), Adam B. Keeton(10), Gary A. Piazza(10), Kate M. Saville(9), Kevin J. Lee(9), Alla Musiyenko(8), Luciana Madeira da Silva(7), Sailen Barik(6), Marie E. Migaud(6), Ashley S. Lindsey(6), Natalie R. Gassman(6), Elaine Gavin(6), Verónica Ramírez‐Alcántara(6), Anna Wilk(5), Jianfeng Li(5), Qingming Fang(5), Rasha Q. Al‐Rahahleh(5), Antonio Ward(5)